Akoya Biosciences’ $43.5 Million Common Stock Offering

DLA Piper advised Akoya Biosciences on the deal.Akoya Biosciences (Akoya), a leading biotechnology company that specializes in the development and commercialization of spatial biology solutions, announced…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now